Business Description
Abingdon Health PLC
ISIN : GB00BLF79J41
Total Employee Number:
129Description
Abingdon Health PLC develops, manufactures, and distributes diagnostic devices and provides regulatory consultancy to diagnostics businesses. It offers integrated lateral flow CRO/CDMO services covering feasibility, manufacturing, packaging, kitting, documentation, and commercial support. Segments include Contract Development (milestone-based third-party work, revenue over time by completion), Contract Manufacturing (development/manufacturing via daily consultancy, revenue at customer control point), Product Sales (AbC-19TM, Pocket Diagnostic, PCRD tests, research antibodies, carriage; point in time), and Regulatory Services (IVD/medical device compliance, revenue over time), with key revenue from Regulatory Services. It operates in the UK, USA/Canada, Europe, and rest of world.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.91 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | -0.4 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.63 | |||||
Beneish M-Score | -1.01 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 32 | |||||
3-Year EBITDA Growth Rate | 51 | |||||
3-Year EPS without NRI Growth Rate | 41 | |||||
3-Year FCF Growth Rate | 29.9 | |||||
3-Year Book Growth Rate | -20.1 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 24.78 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 46.24 | |||||
9-Day RSI | 43.25 | |||||
14-Day RSI | 46.65 | |||||
3-1 Month Momentum % | 128.57 | |||||
6-1 Month Momentum % | 128.57 | |||||
12-1 Month Momentum % | 128.57 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.91 | |||||
Quick Ratio | 1.73 | |||||
Cash Ratio | 1.06 | |||||
Days Inventory | 34.87 | |||||
Days Sales Outstanding | 62.8 | |||||
Days Payable | 136.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -16.7 | |||||
Shareholder Yield % | -12.06 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 41.38 | |||||
Operating Margin % | -32.92 | |||||
Net Margin % | -33.88 | |||||
EBITDA Margin % | -24.94 | |||||
FCF Margin % | -27.54 | |||||
OCF Margin % | -23.71 | |||||
ROE % | -53.98 | |||||
ROA % | -32.77 | |||||
ROIC % | -66.59 | |||||
3-Year ROIIC % | 1018.26 | |||||
ROC (Joel Greenblatt) % | -327.63 | |||||
ROCE % | -44.38 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 38.13 | |||||
PS Ratio | 4.9 | |||||
PB Ratio | 3.81 | |||||
Price-to-Tangible-Book | 15.25 | |||||
EV-to-EBIT | -8.96 | |||||
EV-to-EBITDA | -11.57 | |||||
EV-to-Forward-EBITDA | 39.09 | |||||
EV-to-Revenue | 2.87 | |||||
EV-to-Forward-Revenue | 1.67 | |||||
EV-to-FCF | -10.43 | |||||
Price-to-GF-Value | 0.73 | |||||
| Price-to-Net-Current-Asset-Value | 15.25 | |||||
Earnings Yield (Greenblatt) % | -11.16 | |||||
FCF Yield % | -8.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ABDXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Abingdon Health PLC Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 12.911 | ||
| EPS (TTM) ($) | -0.011 | ||
| Beta | 1.6486 | ||
| 3-Year Sharpe Ratio | 0.75 | ||
| 3-Year Sortino Ratio | 34.77 | ||
| Volatility % | 92.41 | ||
| 14-Day RSI | 46.65 | ||
| 14-Day ATR ($) | 0.008943 | ||
| 20-Day SMA ($) | 0.16884 | ||
| 12-1 Month Momentum % | 128.57 | ||
| 52-Week Range ($) | 0.07 - 0.209 | ||
| Shares Outstanding (Mil) | 251.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Abingdon Health PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Abingdon Health PLC Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-10 12:00 | In 169 days | ||
| Annual report for 2026 | 2026-11-13 | In 141 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-11-11 11:00 | In 140 days | ||
| Fourth quarter earnings results for 2026 | 2026-11-11 | In 139 days | ||
| Life Sciences Virtual Investor Forum | 2026-06-25 10:00 | In 1 day | ||
| Second quarter earnings conference call for 2026 | 2026-03-17 11:00 | 0.07 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2026-03-17 | 0.07 (+0.00%) | ||
| General meeting for 2025 | 2025-12-10 12:00 | 0.07 (+0.00%) | ||
| Annual report for 2025 | 2025-11-14 | 0.07 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2025-11-11 11:00 | 0.07 (+0.00%) |
Show
Entries
Abingdon Health PLC Frequently Asked Questions
What is Abingdon Health PLC(ABDXF)'s stock price today?
The current price of ABDXF is $0.15. The 52 week high of ABDXF is $0.21 and 52 week low is $0.07.
When is next earnings date of Abingdon Health PLC(ABDXF)?
The next earnings date of Abingdon Health PLC(ABDXF) is 2026-11-11 Est..
Does Abingdon Health PLC(ABDXF) pay dividends? If so, how much?
Abingdon Health PLC(ABDXF) does not pay dividend.
Guru Commentaries on OTCPK:ABDXF
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| AbC-19â„¢ Rapid Test Available for Purchase by Healthcare Professionals | 2021-02-16 |
Articles on Abingdon Health PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers